Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Cash from Financing Activities: 2020-2025

Historic Cash from Financing Activities for Benitec Biopharma (BNTC) over the last 5 years, with Jun 2025 value amounting to $70.5 million.

  • Benitec Biopharma's Cash from Financing Activities fell 93.65% to $2.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $70.5 million, marking a year-over-year decrease of 16.13%. This contributed to the annual value of $70.5 million for FY2025, which is 3.61% up from last year.
  • Benitec Biopharma's Cash from Financing Activities amounted to $70.5 million in FY2025, which was up 3.61% from $68.0 million recorded in FY2024.
  • In the past 5 years, Benitec Biopharma's Cash from Financing Activities ranged from a high of $70.5 million in FY2025 and a low of $16.0 million during FY2023.
  • For the 3-year period, Benitec Biopharma's Cash from Financing Activities averaged around $51.5 million, with its median value being $68.0 million (2024).
  • Data for Benitec Biopharma's Cash from Financing Activities shows a peak YoY surged of 1,172.43% (in 2021) over the last 5 years.
  • Over the past 4 years, Benitec Biopharma's Cash from Financing Activities (Yearly) stood at $22.5 million in 2021, then reached $16.0 million in 2023, then skyrocketed by 324.78% to $68.0 million in 2024, then grew by 3.61% to $70.5 million in 2025.